What’s new

Oxford Cancer Biomarkers announces biomarker discovery and development deal with Daiichi-Sankyo

Oxford, UK, 29th August 2014 Oxford Cancer Biomarkers Ltd (OCB), the UK-based company developing tests that allow medicines to be

Read More

Oxford Cancer Biomarkers announces issued United States patent

Oxford, UK, 24 July 2014 Oxford Cancer Biomarkers Ltd (OCB), the UK-based company developing tests that allow medicines to be

Read More

Oxford Cancer Biomarkers announces biomarker discovery deal with AstraZeneca

Oxford, UK, 15th April 2013 Oxford Cancer Biomarkers Ltd (OCB), the UK-based company developing tests that allow medicines to be

Read More

Oxford Cancer Biomarkers appoints David Oxlade as its Chairman

Oxford, UK, 16 October 2013 Oxford Cancer Biomarkers has appointed David Oxlade as Chairman, a key growth milestone for the

Read More

Oxford Cancer Biomarkers appoints Nick McCooke as its CEO

Oxford Cancer Biomarkers has appointed Nick McCooke as CEO, a key growth milestone for the company which aims to benefit

Read More

Quintiles Forms New Biomarker Research and Development Company

Professors David Kerr and Nick La Thangue offer oncology consulting and biomarker R&D activities spun out from the University of

Read More